Direkt zum Inhalt
Merck

CHD4 and SMYD1 repress common transcriptional programs in the developing heart.

Development (Cambridge, England) (2024-04-15)
Wei Shi, Lauren K Wasson, Kerry M Dorr, Zachary L Robbe, Caralynn M Wilczewski, Austin J Hepperla, Ian J Davis, Christine E Seidman, Jonathan G Seidman, Frank L Conlon
ZUSAMMENFASSUNG

Regulation of chromatin states is essential for proper temporal and spatial gene expression. Chromatin states are modulated by remodeling complexes composed of components that have enzymatic activities. CHD4 is the catalytic core of the nucleosome remodeling and deacetylase (NuRD) complex, which represses gene transcription. However, it remains to be determined how CHD4, a ubiquitous enzyme that remodels chromatin structure, functions in cardiomyocytes to maintain heart development. In particular, whether other proteins besides the NuRD components interact with CHD4 in the heart is controversial. Using quantitative proteomics, we identified that CHD4 interacts with SMYD1, a striated muscle-restricted histone methyltransferase that is essential for cardiomyocyte differentiation and cardiac morphogenesis. Comprehensive transcriptomic and chromatin accessibility studies of Smyd1 and Chd4 null embryonic mouse hearts revealed that SMYD1 and CHD4 repress a group of common genes and pathways involved in glycolysis, response to hypoxia, and angiogenesis. Our study reveals a mechanism by which CHD4 functions during heart development, and a previously uncharacterized mechanism regarding how SMYD1 represses cardiac transcription in the developing heart.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
IgG aus Kaninchenserum, reagent grade, ≥95% (SDS-PAGE), essentially salt-free, lyophilized powder
Sigma-Aldrich
Anti-V5 in Kaninchen hergestellte Antikörper, IgG fraction of antiserum
Sigma-Aldrich
Anti-CHD-4 Antibody, clone 3F2/4, clone 3F2/4, from mouse